Pulmonary Circulation,
Год журнала:
2024,
Номер
14(3)
Опубликована: Июль 1, 2024
Abstract
Pulmonary
arterial
hypertension
(PAH)
is
a
poorly
understood
disease
of
the
small
pulmonary
arteries.
vascular
remodeling
and
progressively
rising
resistance
are
hallmarks
that
ultimately
result
in
right
heart
failure.
Several
genetic
mutations,
most
notably
bone
morphogenetic
protein
receptor
type
2,
have
causal
association
with
heritable
forms
PAH.
Mutations
neurogenic
locus
notch
homolog
3
(
NOTCH3)
been
reported
adults
children
PAH,
but
whether
NOTCH3
causally
associated
PAH
debated.
With
this
case
report,
we
describe
clinical
characteristics,
comorbidities,
exposure
history
an
adult
patient
multiple
sclerosis
who
was
found
to
missense
mutation
leflunomide.
American Journal of Respiratory and Critical Care Medicine,
Год журнала:
2023,
Номер
208(5), С. 528 - 548
Опубликована: Июль 14, 2023
Major
advances
in
pulmonary
arterial
hypertension,
hypertension
(PH)
associated
with
lung
disease,
and
chronic
thromboembolic
PH
cast
new
light
on
the
pathogenetic
mechanisms,
epidemiology,
diagnostic
approach,
therapeutic
armamentarium
for
vascular
disease.
Here,
we
summarize
key
basic,
translational,
clinical
reports,
emphasizing
findings
that
build
current
state-of-the-art
research.
This
review
includes
cutting-edge
progress
translational
biology,
a
guide
to
diagnosis
of
patients
practice,
incorporating
recent
definition
revisions
continue
emphasis
early
detection
management
is
reviewed
including
an
overview
evolving
considerations
approach
treatment
cardiopulmonary
comorbidities,
as
well
discussion
groundbreaking
sotatercept
data
hypertension.
A
central
feature
of
progressive
vascular
remodeling
is
altered
smooth
muscle
cell
(SMC)
homeostasis;
however,
the
understanding
how
different
populations
contribute
to
this
process
limited.
Here,
we
utilized
single-cell
RNA
sequencing
provide
insight
into
cellular
composition
changes
within
isolated
pulmonary
arteries
(PAs)
from
arterial
hypertension
and
donor
lungs.
Our
results
revealed
that
skewed
balanced
communication
network
between
immune
structural
cells,
in
particular
SMCs.
Comparative
analysis
with
murine
PAs
showed
human
harbored
heterogeneous
SMC
an
abundant
intermediary
cluster
displaying
a
gradient
transition
SMCs
adventitial
fibroblasts.
Transcriptionally
distinct
were
enriched
specific
biological
processes
could
be
differentiated
4
major
clusters:
oxygen
sensing
(enriched
pericytes),
contractile,
synthetic,
fibroblast-like.
End-stage
was
associated
phenotypic
shift
preexisting
accumulation
synthetic
neointima.
Distinctly
regulated
genes
clusters
built
nonredundant
regulatory
hubs
encompassing
stress
response
differentiation
regulators.
The
current
study
provides
blueprint
molecular
on
level
are
defining
pathological
process.
Physiological Reviews,
Год журнала:
2022,
Номер
103(3), С. 1827 - 1897
Опубликована: Ноя. 24, 2022
The
pulmonary
circulation
is
a
low-resistance,
low-pressure,
and
high-compliance
system
that
allows
the
lungs
to
receive
entire
cardiac
output.
Pulmonary
arterial
pressure
function
of
output
vascular
resistance,
resistance
inversely
proportional
fourth
power
intraluminal
radius
artery.
Therefore,
very
small
decrease
lumen
diameter
results
in
significant
increase
pressure.
hypertension
fatal
progressive
disease
with
poor
prognosis.
Regardless
initial
pathogenic
triggers,
sustained
vasoconstriction,
concentric
remodeling,
occlusive
intimal
lesions,
situ
thrombosis,
wall
stiffening
are
major
direct
causes
for
elevated
patients
other
forms
precapillary
hypertension.
In
this
review,
we
aim
discuss
basic
principles
physiological
mechanisms
involved
regulation
lung
hemodynamics
function,
changes
vasculature
contribute
increased
pressure,
development
progression
We
focus
on
reviewing
roles
membrane
receptors,
ion
channels,
intracellular
Ca
Frontiers in Immunology,
Год журнала:
2023,
Номер
14
Опубликована: Июнь 28, 2023
Pulmonary
hypertension
(PH)
is
a
progressive,
pulmonary
vascular
disease
with
high
morbidity
and
mortality.
Unfortunately,
the
pathogenesis
of
PH
complex
remains
unclear.
Existing
studies
have
suggested
that
inflammatory
factors
are
key
in
PH.
Interleukin-6
(IL-6)
multifunctional
cytokine
plays
crucial
role
regulation
immune
system.
Current
reveal
IL-6
elevated
serum
patients
it
negatively
correlated
lung
function
those
patients.
Since
one
most
important
mediators
inflammation
PH,
signaling
mechanisms
targeting
may
become
therapeutic
targets
for
this
disease.
In
review,
we
detailed
potential
accelerating
process
specific
pathways.
We
also
summarized
current
drugs
these
pathways
to
treat
hope
study
will
provide
more
theoretical
basis
targeted
treatment
future.
Current Opinion in Cell Biology,
Год журнала:
2024,
Номер
86, С. 102302 - 102302
Опубликована: Янв. 9, 2024
Notch
signaling
controls
multiple
aspects
of
embryonic
development
and
adult
homeostasis.
Alagille
syndrome
is
usually
caused
by
a
single
mutation
in
the
jagged
canonical
ligand
1
(JAG1),
manifests
with
liver
disease
cardiovascular
symptoms
that
are
direct
consequence
JAG1
haploinsufficiency.
Recent
insights
into
Jag1/Notch-controlled
developmental
homeostatic
processes
explain
how
pathology
develops
hepatic
systems
and,
together
recent
elucidation
mechanisms
modulating
regeneration,
provide
basis
for
therapeutic
efforts.
Importantly,
presentation
can
be
regulated
genetic
modifiers,
may
also
therapeutically
leverageable.
Here,
we
summarize
Jag1
relevance
to
syndrome,
focused
on
Jag1/Notch
functions
Frontiers in Cell and Developmental Biology,
Год журнала:
2023,
Номер
11
Опубликована: Сен. 12, 2023
Pulmonary
arterial
hypertension
(PAH)
is
a
severe
disease
resulting
from
progressive
increases
in
pulmonary
vascular
resistance
and
remodeling,
ultimately
leading
to
right
ventricular
failure
even
death.
Hypoxia,
inflammation,
immune
reactions,
epigenetic
modifications
all
play
significant
contributory
roles
the
mechanism
of
PAH.
Increasingly,
changes
their
modifying
factors
involved
reprogramming
through
regulation
methylation
or
microenvironment
have
been
identified.
Among
them,
histone
lactylation
new
post-translational
modification
(PTM),
which
provides
novel
visual
angle
on
functional
lactate
promising
diagnosis
treatment
method
for
This
review
detailed
introduces
function
as
an
important
molecule
PAH,
effects
N6-methyladenosine
(m6A)
cells.
It
perspective
further
explore
development
modification.
Frontiers in Cardiovascular Medicine,
Год журнала:
2023,
Номер
10
Опубликована: Март 3, 2023
Pulmonary
hypertension
has
high
disability
and
mortality
rates.
Among
them,
pulmonary
caused
by
left
heart
disease
(PH-LHD)
is
the
most
common
type.
According
to
2022
ESC/ERS
Guidelines
for
diagnosis
treatment
of
hypertension,
PH-LHD
classified
as
group
2
hypertension.
belongs
postcapillary
which
distinguished
from
other
types
because
its
elevated
artery
wedge
pressure.
includes
PH
due
systolic
or
diastolic
ventricular
dysfunction,
mitral
aortic
valve
congenital
disease.
The
primary
strategy
in
managing
optimizing
underlying
cardiac
Recent
clinical
studies
have
found
that
mechanical
unloading
ventricle
an
implantable
non-pulsatile
assist
device
with
continuous
flow
properties
can
reverse
patients
failure.
However,
specific
therapies
LHD
not
yet
been
identified.
Treatments
specifically
target
could
slow
progression
potentially
improve
severity,
leading
far
better
outcomes.
Therefore,
exploring
current
research
on
pathogenesis
important.
This
paper
summarizes
classifies
articles
provide
references
mechanism
PH-LHD,
particularly
molecular
targeted
therapy.